PMDA drug package insert
ケンブラン吸入粉末溶解用100㎎
PMDA Prescription drug · 参天製薬株式会社 · package insert Apr 25, 2025
Key facts
| Brand names | ケンブラン吸入粉末溶解用100㎎ |
|---|---|
| Nonproprietary names | メタコリン塩化物 |
| Companies | 製造販売（輸入）元／参天製薬株式会社, ライセンス提携／methapharmケンブラン/KENBRANはMethapharm Inc.の登録商標です。 |
| Product type | Prescription drug |
| Therapeutic category | コリン作動薬 気道過敏性検査用 |
| Therapeutic category codes | 87729 |
| YJ codes | 7290708G1033 |
| Approval numbers | 22800AMX00027 |
| Package insert edition | 第2版、再審査結果 |
| Package insert date | Apr 25, 2025 |
| PMDA document key | 300237_7290708G1033_1 |
| PMDA company code | 300237 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: